15 MIN DELAY
Latest Share Price
Latest NewsPress Releases Regulatory News
About our products
We’re making giant leaps with smaller, increasingly less invasive steps. We can pinpoint the problems inside us and deliver treatments exactly where they’re needed most.
Our antidote products are used in hospital emergency rooms and intensive care units. They address conditions for which there are limited or no other existing treatment options.
Named Patient Supplies
Under strict regulations, we are permitted to allow healthcare professionals access to certain products still in the pre-approval phase.
15 Jun 2016
BTG plc acquires Galil Medical
BTG expands its Interventional Oncology franchise with the acquisition of Galil Medical, a leader in cryoablationRead more
Here at BTG we value the contribution of every employee and recognise the part we all play in achieving our goal to become a self-sustaining international specialist healthcare business.Careers
Inspired by patient need, we are investing to expand our portfolio with products that address today’s healthcare challenges.Read more
17 May 2016
Financial Results Centre 2016
Results statement, video, webcast details, and presentation for the year ending 31 March 2016Find out more
01 Mar 2016
BTG Launches ‘SnakeBite911’ App
Our first interactive mobile app, SnakeBite911, is intended to educate people about North American pit vipers, how to avoid them and what to do if someone gets bitten.Visit the App Store to find out more
We are committed to ensuring that we provide full, accurate, balanced and timely information to the medical professionals who prescribe our products.Healthcare Professionals
We’re committed to delivering value and sustainable growth while fulfilling our obligations to all of our stakeholders and the communities where we live and work.Responsibility